Azacitidine 150mg tablet, Azacitidine 200mg tablet: film- coated tablet, azacitidine, PEMBROLIZUMAB, azacitidine
CC-486-NSCL-001
Phase 2 small_molecule active
Quick answer
Azacitidine 150mg tablet, Azacitidine 200mg tablet: film- coated tablet, azacitidine, PEMBROLIZUMAB, azacitidine for Second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) is a Phase 2 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active